XIAOMI-W
01810
TRIP.COM-S
09961
JD HEALTH
06618
BILIBILI-W
09626
JD-SW
09618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 54.08%441.67M | -85.04%297.89M | -77.26%286.66M | 5,026.08%1.99B | 12,086.22%1.26B | -88.56%38.86M | -95.87%10.35M | -85.69%339.51M | -88.75%250.29M | -16.23%2.37B |
Operating income | 54.08%441.67M | -85.04%297.89M | -77.26%286.66M | 5,026.08%1.99B | 12,086.22%1.26B | -88.56%38.86M | -95.87%10.35M | -85.69%339.51M | -88.75%250.29M | -16.23%2.37B |
Cost of sales | -68.61%-348.92M | 86.51%-224.31M | 80.70%-206.94M | -7,028.23%-1.66B | -8,071.74%-1.07B | 85.60%-23.32M | 90.15%-13.12M | 87.47%-161.97M | 89.40%-133.17M | 23.17%-1.29B |
Operating expenses | -68.61%-348.92M | 86.51%-224.31M | 80.70%-206.94M | -7,028.23%-1.66B | -8,071.74%-1.07B | 85.60%-23.32M | 90.15%-13.12M | 87.47%-161.97M | 89.40%-133.17M | 23.17%-1.29B |
Gross profit | 16.34%92.75M | -77.68%73.58M | -57.78%79.72M | 2,021.30%329.61M | 6,911.58%188.82M | -91.25%15.54M | -102.37%-2.77M | -83.55%177.55M | -87.89%117.12M | -6.07%1.08B |
Selling expenses | -25.10%-87.39M | 53.37%-83.7M | 18.57%-69.86M | -600.57%-179.49M | -312.86%-85.79M | 60.11%-25.62M | 56.36%-20.78M | 70.20%-64.23M | 73.07%-47.61M | -69.66%-215.52M |
Administrative expenses | -3.70%-56.46M | 3.22%-104.69M | 0.76%-54.45M | 5.71%-108.17M | -8.36%-54.86M | -23.58%-114.71M | -9.85%-50.63M | 31.79%-92.83M | 29.37%-46.09M | -14.17%-136.08M |
Revaluation surplus | -387.92%-16.56M | -159.57%-8.87M | -185.13%-3.39M | 134.04%14.89M | -108.98%-1.19M | 46.88%-43.74M | 150.41%13.26M | 10.09%-82.34M | 32.05%-26.29M | -229.75%-91.58M |
-Changes in the fair value of investment property | -152.63%-2M | -77.15%2.71M | 1,287.50%3.8M | 216.88%11.88M | -101.34%-320K | 105.82%3.75M | 345.93%23.97M | 27.76%-64.44M | 74.81%-9.75M | -226.37%-89.2M |
-Changes in the fair value of derivative financial instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.4M |
-Changes in the fair value of financial assets | -102.35%-14.56M | -484.85%-11.58M | -726.78%-7.19M | 106.34%3.01M | 91.88%-870K | -165.26%-47.49M | 35.27%-10.71M | -987.56%-17.9M | ---16.55M | --2.02M |
Impairment and provision | -941.65%-7.3M | -582.48%-692.64M | 98.59%-701K | -15,832.18%-101.49M | -5,462.39%-49.84M | 99.14%-637K | -115.53%-896K | -237.10%-73.83M | --5.77M | -124.65%-21.9M |
-Impairment of property, machinery and equipment | ---7.3M | -721.58%-692.36M | ---- | ---84.27M | ---38.13M | ---- | ---- | -492.37%-80M | ---- | -115.20%-13.51M |
-Other impairment is provision | ---- | 98.37%-281K | 94.01%-701K | -2,602.83%-17.22M | -1,206.36%-11.71M | -110.32%-637K | -115.53%-896K | 173.50%6.17M | --5.77M | ---8.4M |
Operating interest expense | ---- | ---- | ---- | ---- | -37.20%-50.16M | 8.08%-71.21M | 10.59%-36.56M | 18.04%-77.47M | 16.23%-40.89M | -8.25%-94.52M |
Special items of operating profit | -13.25%24.33M | -101.41%-1.02M | 4.24%28.05M | -17.12%72.52M | -14.49%26.91M | -16.13%87.5M | -61.15%31.47M | 32.14%104.33M | 173.98%80.99M | 27.86%78.96M |
Operating profit | -145.39%-50.63M | -3,032.54%-817.33M | 20.99%-20.63M | 118.23%27.87M | 60.97%-26.12M | -40.49%-152.88M | -255.63%-66.92M | -118.19%-108.82M | -93.56%43M | -42.26%598.36M |
Financing cost | -28.02%-103.3M | -42.80%-181.01M | ---80.69M | ---126.76M | ---- | ---- | ---- | ---- | ---- | ---- |
Share of profit from joint venture company | -33.83%248.81M | -17.12%262.53M | 247.98%375.99M | -26.44%316.78M | -49.10%108.05M | -26.49%430.63M | 329.56%212.28M | 3,010.90%585.78M | -0.27%49.42M | 152.93%18.83M |
Earning before tax | -65.46%94.88M | -437.70%-735.81M | 235.24%274.67M | -21.55%217.89M | -43.64%81.93M | -41.77%277.75M | 57.30%145.37M | -22.72%476.96M | -87.11%92.41M | -38.33%617.19M |
Tax | 99.31%-51K | 10.86%-6.27M | 48.59%-7.39M | -198.20%-7.03M | -539.35%-14.37M | 181.52%7.16M | 116.94%3.27M | 93.95%-8.78M | 86.01%-19.3M | 14.80%-145.31M |
After-tax profit from continuing operations | -64.52%94.83M | -451.94%-742.07M | 295.61%267.28M | -25.99%210.85M | -54.55%67.56M | -39.14%284.91M | 103.31%148.64M | -0.78%468.18M | -87.37%73.11M | -43.16%471.88M |
Earning after tax | -64.52%94.83M | -451.94%-742.07M | 295.61%267.28M | -25.99%210.85M | -54.55%67.56M | -39.14%284.91M | 103.31%148.64M | -0.78%468.18M | -87.37%73.11M | -43.16%471.88M |
Minority profit | -397.36%-2.07M | -4,049.53%-8.8M | -540.00%-416K | -26.95%-212K | -409.52%-65K | -111.66%-167K | -98.32%21K | -90.16%1.43M | 317.53%1.25M | -95.59%14.56M |
Profit attributable to shareholders | -63.80%96.9M | -447.42%-733.28M | 295.84%267.7M | -25.96%211.07M | -54.50%67.63M | -38.92%285.08M | 106.82%148.62M | 2.06%466.75M | -87.60%71.86M | -8.59%457.32M |
Basic earnings per share | -63.64%0.0064 | -446.76%-0.0482 | 300.00%0.0176 | -26.06%0.0139 | -55.10%0.0044 | -38.76%0.0188 | 108.51%0.0098 | 1.99%0.0307 | -87.66%0.0047 | -8.51%0.0301 |
Diluted earnings per share | -63.64%0.0064 | -446.76%-0.0482 | 300.00%0.0176 | -26.06%0.0139 | -55.10%0.0044 | -38.76%0.0188 | 108.51%0.0098 | 1.99%0.0307 | -87.66%0.0047 | -8.51%0.0301 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.